D-0326-2024 Class II Ongoing
FDA drug recall D-0326-2024 was initiated by Apotex Corp. on Feb 9, 2024 and is designated Class II. Reason for recall: CGMP Deviations: potential presence of Burkholderia cepacia complex The recall status is ongoing. Affected quantity: 292,752 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 28, 2024
- Initiation Date
- Feb 9, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 292,752 bottles
Product description
Fluticasone Propionate Nasal Spray USP 50mcg, 120 Metered Sprays - 16 g net fill, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9, Manufactured for: Apotex Corp Weston, FL 33326. NDC 60505-0829-1
Reason for recall
CGMP Deviations: potential presence of Burkholderia cepacia complex
Distribution pattern
Nationwide in the USA
Code information
Lot number # TX5274 Exp. 09/30/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0326-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026